Literature DB >> 8063741

An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.

G M Cesarman1, C A Guevara, K A Hajjar.   

Abstract

In the preceding paper (Hajjar, K. A., Jacovina, A. T., and Chacko, J. (1994) J. Biol. Chem. 269, 21191-21197), we identified a M(r) = 40,000 endothelial cell receptor for tissue plasminogen activator (t-PA) and plasminogen (PLG) as the calcium- and phospholipid-binding protein, annexin II (Ann-II). Here, we examined the effect of Ann-II on t-PA-dependent plasminogen activation in a purified system. Purified native Ann-II bound t-PA, plasminogen, and plasmin with high affinity (Kd = 25 nM, 161 nM, and 75 nM, respectively). At fixed plasminogen concentrations, preincubation with purified native Ann-II was associated with an approximately 21-fold increase in the rate of Glu-PLG activation and an approximately 14-fold increase in activation of Lys-PLG. Three irrelevant proteins had no effect on plasmin formation, while fibrinogen increased the rate of Glu-PLG activation by approximately 4-fold. Annexin-II-mediated enhancement of t-PA-dependent plasminogen activation was 90-95% inhibited by epsilon-aminocaproic acid or by pretreatment of Ann-II with carboxypeptidase B, indicating a carboxyl-terminal lysine-dependent interaction. Kinetic analyses revealed that Ann-II conferred an approximately 60-fold increase in catalytic efficiency upon t-PA-dependent activation of either Glu-PLG or Lys-PLG. Thus, Ann-II-mediated assembly of plasminogen and t-PA may promote and localize constitutive plasmin generation on the surface of the blood vessel wall.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063741

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  85 in total

1.  Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosis.

Authors:  David S Ucker; Mohit Raja Jain; Goutham Pattabiraman; Karol Palasiewicz; Raymond B Birge; Hong Li
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 2.  Impaired fibrinolysis in the antiphospholipid syndrome.

Authors:  Katie A Krone; Kristi L Allen; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

3.  Tissue Plasminogen Activator: Side Effects and Signaling.

Authors:  Ling Lin; Kebin Hu
Journal:  J Drug Des Res       Date:  2014-09-25

4.  Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.

Authors:  Xiang Fan; Zhanyang Yu; Jianxiang Liu; Ning Liu; Katherine A Hajjar; Karen L Furie; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 5.  The endothelial cell annexin A2 system and vascular fibrinolysis.

Authors:  MaryAnn Dassah; Arun B Deora; Kaili He; Katherine A Hajjar
Journal:  Gen Physiol Biophys       Date:  2009       Impact factor: 1.512

Review 6.  Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2013-11-12       Impact factor: 2.490

7.  Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.

Authors:  Taro Sakai; Krishnakumar Balasubramanian; Sourindra Maiti; Jyotsna B Halder; Alan J Schroit
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

Review 8.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

9.  beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation.

Authors:  Chunya Bu; Lei Gao; Weidong Xie; Jainwei Zhang; Yuhong He; Guoping Cai; Keith R McCrae
Journal:  Arthritis Rheum       Date:  2009-02

Review 10.  Annexin A2: biology and relevance to the antiphospholipid syndrome.

Authors:  E Cockrell; R G Espinola; K R McCrae
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.